Hepatocellular Carcinoma: Current Management and Future Development—Improved Outcomes with Surgical Resection
Open Access
- 1 January 2011
- journal article
- Published by Hindawi Limited in International Journal of Hepatology
- Vol. 2011, 1-10
- https://doi.org/10.4061/2011/728103
Abstract
Currently, surgical resection is the treatment strategy offering the best long-term outcomes in patients with hepatocellular carcinoma (HCC). Especially for advanced HCC, surgical resection is the only strategy that is potentially curative, and the indications for surgical resection have expanded concomitantly with the technical advances in hepatectomy. A major problem is the high recurrence rate even after curative resection, especially in the remnant liver. Although repeat hepatectomy may prolong survival, the suitability may be limited due to multiple tumor recurrence or background liver cirrhosis. Multimodality approaches combining other local ablation or systemic therapy may help improve the prognosis. On the other hand, minimally invasive, or laparoscopic, hepatectomy has become popular over the last decade. Although the short-term safety and feasibility has been established, the long-term outcomes have not yet been adequately evaluated. Liver transplantation for HCC is also a possible option. Given the current situation of donor shortage, however, other local treatments should be considered as the first choice as long as liver function is maintained. Non-transplant treatment as a bridge to transplantation also helps in decreasing the risk of tumor progression or death during the waiting period. The optimal timing for transplantation after HCC recurrence remains to be investigated.Keywords
This publication has 126 references indexed in Scilit:
- An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombusZeitschrift für Krebsforschung und Klinische Onkologie, 2010
- The International Position on Laparoscopic Liver SurgeryAnnals of Surgery, 2009
- World Review of Laparoscopic Liver Resection—2,804 PatientsAnnals of Surgery, 2009
- Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysisHepatology, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be ExpandedAnnals of Surgery, 2007
- Evaluation of 300 Minimally Invasive Liver Resections at a Single InstitutionAnnals of Surgery, 2007
- Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinomaEuropean Journal of Surgical Oncology, 2006
- Implication of Frequent Local Ablation Therapy for Intrahepatic Recurrence in Prolonged Survival of Patients With Hepatocellular Carcinoma Undergoing Hepatic ResectionAnnals of Surgery, 2006